IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients
Acta Pharmacologica Sinica2017Vol. 38(3), pp. 415–423
Citations Over TimeTop 11% of 2017 papers
Mouze Liu, Haiyan He, Yueli Zhang, HU Yong-fang, Fazhong He, Jian‐Quan Luo, Zhiying Luo, Xiaoping Chen, Zhaoqian Liu, Hong‐Hao Zhou, Mingjie Shao, Yingzi Ming, Hua‐Wen Xin, Wei Zhang
Related Papers
- → CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients(2020)22 cited
- A systematic review and meta-analysis recite the efficacy of Tacrolimus treatment in renal transplant patients in association with genetic variants of CYP3A5 gene.(2023)
- Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients.(2011)
- → Influence of CYP3A5 polymorphism on tacrolimus blood concentrations in renal transplant patients(2005)8 cited
- Influence of CYP3A5 polymorphism on tacrolimus blood concentrations in renal transplant patients(2005)